tiprankstipranks
Advertisement
Advertisement

XTNT Stock Latest News

Xtant Medical Balances New Growth Bets With Near-Term Pain
Company AnnouncementsXtant Medical Balances New Growth Bets With Near-Term Pain
6d ago
XTNT
Xtant Medical’s HEMOBLAST Deal with Dilon: High Sales Spend, Single‑Supplier Dependence and Termination Risk Threaten Returns
PremiumCompany Announcements
Xtant Medical’s HEMOBLAST Deal with Dilon: High Sales Spend, Single‑Supplier Dependence and Termination Risk Threaten Returns
12d ago
XTNT
Xtant Medical Boosts 2026 Outlook Amid Tough Quarter
PremiumCompany Announcements
Xtant Medical Boosts 2026 Outlook Amid Tough Quarter
12d ago
XTNT
Xtant Medical reports Q1 EPS (2c) vs. 0c last year
PremiumThe Fly
Xtant Medical reports Q1 EPS (2c) vs. 0c last year
13d ago
XTNT
Xtant Medical raises FY26 revenue view to $101M-$105M from $95M-$99M
PremiumThe Fly
Xtant Medical raises FY26 revenue view to $101M-$105M from $95M-$99M
13d ago
XTNT
Xtant Medical Updates Q1 Results and Raises 2026 Guidance
PremiumCompany AnnouncementsXtant Medical Updates Q1 Results and Raises 2026 Guidance
13d ago
8K
XTNT
Xtant Medical resumed with a Buy at Maxim
Premium
The Fly
Xtant Medical resumed with a Buy at Maxim
1M ago
XTNT
Xtant Medical Expands Portfolio with HEMOBLAST Distribution Deal
Premium
Company Announcements
Xtant Medical Expands Portfolio with HEMOBLAST Distribution Deal
1M ago
8K
XTNT
Xtant Medical acquires U.S. distribution rights to Dilon’s Hemoblast Bellows
PremiumThe Fly
Xtant Medical acquires U.S. distribution rights to Dilon’s Hemoblast Bellows
1M ago
XTNT
Xtant Medical Warns of 2026 Profit Hit as One‑Time License Revenue and SimpliMax™ Reimbursements Fade
PremiumCompany Announcements
Xtant Medical Warns of 2026 Profit Hit as One‑Time License Revenue and SimpliMax™ Reimbursements Fade
2M ago
XTNT
Xtant Medical Earnings Call Highlights Profitability Turnaround
PremiumCompany Announcements
Xtant Medical Earnings Call Highlights Profitability Turnaround
2M ago
XTNT
Xtant Medical reports Q4 EPS 0c vs. (2c) last year
PremiumThe Fly
Xtant Medical reports Q4 EPS 0c vs. (2c) last year
2M ago
XTNT
Xtant Medical sees 2026 revenue $95M-$99M, consensus $110.1M
PremiumThe FlyXtant Medical sees 2026 revenue $95M-$99M, consensus $110.1M
2M ago
XTNT
XTNT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
XTNT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
XTNT
Xtant Medical Boosts Liquidity After Companion Spine Repayment
Premium
Company Announcements
Xtant Medical Boosts Liquidity After Companion Spine Repayment
3M ago
8K
XTNT
Xtant Medical says transactions with Companion Spine now finalized
PremiumThe Fly
Xtant Medical says transactions with Companion Spine now finalized
3M ago
XTNT
Xtant Medical Extends Note Maturity After Asset Divestitures
PremiumCompany Announcements
Xtant Medical Extends Note Maturity After Asset Divestitures
4M ago
8K
XTNT
Xtant Medical announces commercial launch of Strata
PremiumThe Fly
Xtant Medical announces commercial launch of Strata
6M ago
XTNT
Xtant Medical Sells Assets to Companion Spine
PremiumCompany Announcements
Xtant Medical Sells Assets to Companion Spine
6M ago
8K
XTNT
Xtant Medical Reports Strong Q3 2025 Results
PremiumCompany AnnouncementsXtant Medical Reports Strong Q3 2025 Results
7M ago
XTNT
Xtant Medical Holdings’ Earnings Call: Positive Growth Amid Challenges
Premium
Company Announcements
Xtant Medical Holdings’ Earnings Call: Positive Growth Amid Challenges
7M ago
XTNT
Xtant Medical Holdings: Buy Rating Affirmed on Strong Financial Performance and Strategic Growth Potential
Premium
Ratings
Xtant Medical Holdings: Buy Rating Affirmed on Strong Financial Performance and Strategic Growth Potential
7M ago
XTNT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >